Patent · US Active

Transdermal delivery systems

US8337883B2 · kind B2 · utility

3Cited by

50References

17Claims

0Family size

Assignee

Durect Corporation · US

Inventors

Su Il Yum · Los Altos, US
Sung-Yun Kwon · Cambridge, US
Xiaoping Song · Saratoga, US
James E. Brown · Los Gatos, US

Key dates

Filing date	Oct 29, 2007
Grant date	Dec 25, 2012
Priority date	—
Expiry date	May 22, 2031

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P29/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are bupivacaine transdermal delivery systems, and related methods.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.